Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Regulation of T cell expansion by antigen presentation dynamics.

Mayer A, Zhang Y, Perelson AS, Wingreen NS.

Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):5914-5919. doi: 10.1073/pnas.1812800116. Epub 2019 Mar 8.

2.

MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1.

Li P, Xiao Z, Luo J, Zhang Y, Lin L.

J Cell Mol Med. 2019 Apr;23(4):2475-2488. doi: 10.1111/jcmm.14121. Epub 2019 Feb 1.

3.

Association of Sustained Response Duration With Survival After Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma.

Zhang Y, Zhang M, Chen M, Mei J, Xu L, Guo R, Lin X, Li J, Peng Z.

JAMA Netw Open. 2018 Oct 5;1(6):e183213. doi: 10.1001/jamanetworkopen.2018.3213.

4.

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation.

Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhang Y, Chen M.

Cancers (Basel). 2018 Oct 10;10(10). pii: E378. doi: 10.3390/cancers10100378.

5.

A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma.

Chen J, Fang A, Chen M, Tuoheti Y, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhu H, Zhang Y.

Cancer Med. 2018 Oct;7(10):5027-5035. doi: 10.1002/cam4.1787. Epub 2018 Sep 27.

6.

High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis.

Shakya M, Zhou A, Dai D, Zhong Q, Zhou Z, Zhang Y, Li X, Bholee AK, Chen M.

Cancer Biomark. 2018;22(4):611-619. doi: 10.3233/CBM-170091.

7.

Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis.

Chen J, Lu S, Zhang Y, Xu L, Chen J, Wang J, Chen M, Zhang R, Zhou Z.

J Cancer. 2018 Apr 19;9(10):1745-1753. doi: 10.7150/jca.24568. eCollection 2018.

8.

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.

Zhang Y, Huang J, Chen J, Yang K, Chen J, Xu L, Zhou Z, Chen M.

Cancer Manag Res. 2018 Mar 27;10:599-611. doi: 10.2147/CMAR.S160047. eCollection 2018.

9.

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma.

Zhang Y, Xi S, Chen J, Zhou D, Gao H, Zhou Z, Xu L, Chen M.

J Cancer. 2017 Aug 25;8(15):2992-3000. doi: 10.7150/jca.21038. eCollection 2017.

10.

Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients.

Chen J, Huang J, Chen M, Yang K, Chen J, Wang J, Xu L, Zhou Z, Zhang Y.

J Cancer. 2017 Aug 25;8(15):2984-2991. doi: 10.7150/jca.20978. eCollection 2017.

11.

A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model.

Shen L, Wu Y, Ge L, Zhang Y, Wang Q, Qian J, Qiu Z, Ge J.

Int J Cardiovasc Imaging. 2017 Oct;33(10):1473-1481. doi: 10.1007/s10554-017-1148-5. Epub 2017 Jun 21.

PMID:
28639098
12.

MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters.

Zhou HC, Fang JH, Shang LR, Zhang ZJ, Sang Y, Xu L, Yuan Y, Chen MS, Zheng L, Zhang Y, Zhuang SM.

J Pathol. 2016 Dec;240(4):450-460. doi: 10.1002/path.4804. Epub 2016 Oct 18.

PMID:
27577856
13.

First-Passage Processes in the Genome.

Zhang Y, Dudko OK.

Annu Rev Biophys. 2016 Jul 5;45:117-34. doi: 10.1146/annurev-biophys-062215-010925. Review.

PMID:
27391924
14.
15.

Response of nitric and nitrous oxide fluxes to N fertilizer application in greenhouse vegetable cropping systems in southeast China.

Zhang Y, Lin F, Jin Y, Wang X, Liu S, Zou J.

Sci Rep. 2016 Feb 5;6:20700. doi: 10.1038/srep20700.

16.

Expression of Pim-3 in colorectal cancer and its relationship with prognosis.

Zhou Z, Zhang R, Wang R, Zhang Y, Xu L, Chen J, Zhang J, Huang Z, Chen M, Pan Z.

Tumour Biol. 2016 Jul;37(7):9151-6. doi: 10.1007/s13277-016-4806-7. Epub 2016 Jan 14.

PMID:
26768612
17.

A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.

Zhou D, Zhang Y, Xu L, Zhou Z, Huang J, Chen M.

Sci Rep. 2015 Oct 21;5:15263. doi: 10.1038/srep15263.

18.

Intrinsic Functional Connectivity Patterns Predict Consciousness Level and Recovery Outcome in Acquired Brain Injury.

Wu X, Zou Q, Hu J, Tang W, Mao Y, Gao L, Zhu J, Jin Y, Wu X, Lu L, Zhang Y, Zhang Y, Dai Z, Gao JH, Weng X, Zhou L, Northoff G, Giacino JT, He Y, Yang Y.

J Neurosci. 2015 Sep 16;35(37):12932-46. doi: 10.1523/JNEUROSCI.0415-15.2015.

19.

A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.

Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM.

Lancet Oncol. 2015 Jul;16(7):804-15. doi: 10.1016/S1470-2045(15)00048-0. Epub 2015 Jun 15.

PMID:
26088272
20.

A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner.

Fang JH, Zhou HC, Zhang C, Shang LR, Zhang L, Xu J, Zheng L, Yuan Y, Guo RP, Jia WH, Yun JP, Chen MS, Zhang Y, Zhuang SM.

Hepatology. 2015 Aug;62(2):452-65. doi: 10.1002/hep.27760. Epub 2015 Apr 22.

PMID:
25711742

Supplemental Content

Loading ...
Support Center